证券记录 · 已归档季度
DVA
DaVita Inc. · Healthcare · Medical - Care Facilities
19被追踪持有人
+1Δ持有人
47.03M持有股份
$6.25B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 -5.0% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 39.30K | $6.70M | n/a | −2 |
| Q2 2026 | 149 | +2 | 51.82M | $11.52B | +7 | −6 |
| Q1 2026 | 151 | -1 | 53.76M | $8.26B | +7 | −9 |
| Q4 2025 | 151 | +2 | 59.24M | $6.69B | +3 | n/a |
| Q3 2025 | 19 | +1 | 47.03M | $6.25B | +1 | −1 |
| Q2 2025 | 16 | 0 | 47.42M | $6.75B | n/a | n/a |
| Q1 2025 | 13 | -2 | 39.39M | $6.03B | n/a | −2 |
| Q4 2024 | 15 | 0 | 40.69M | $6.09B | +1 | −1 |
| Q3 2024 | 14 | -1 | 38.81M | $6.36B | n/a | −1 |
| Q2 2024 | 15 | n/a | 39.04M | $5.41B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Berkshire Hathaway ✦ | 32.16M | -4.8% | $4.27B | 1.6% | ▼ Trim | 6 | SEC ↗ ×2 |
| 2 | The Vanguard Group ✦ (被动) | 4.23M | -10.9% | $561.76M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (被动) | 3.58M | -13.1% | $475.14M | 0.0% | ▼ Trim | 2 | SEC ↗ ×20 |
| 4 | State Street Global Advisors ✦ (被动) | 1.83M | -12.3% | $243.79M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 1.41M | n/a | $186.80M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 6 | Geode Capital Management ✦ (被动) | 1.02M | -7.8% | $135.43M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | JPMorgan Chase ✦ | 668.73K | n/a | $88.85M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 8 | Arrowstreet Capital ✦ | 553.81K | +109.7% | $73.58M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Millennium Management ✦ | 457.94K | +9.1% | $60.85M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 450.20K | +212.7% | $59.82M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 240.72K | n/a | $31.98M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Fidelity (FMR) ✦ | 133.60K | -3.0% | $17.75M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | D. E. Shaw & Co. ✦ | 75.78K | +45.5% | $10.07M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | T. Rowe Price ✦ | 60.08K | -13.4% | $7.98M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 59.18K | -30.6% | $7.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 45.43K | 新增 | $6.04M | 0.0% | New | 1 | SEC ↗ ×3 |
| 17 | Bridgewater Associates ✦ | 26.80K | -76.1% | $3.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 19.44K | -41.8% | $2.56M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 19 | Wellington Management ✦ | 8.81K | +2.9% | $1.17M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $6.04M | 0.0% |
已清仓
| Norges Bank | $32.99M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 579 持有人, 61.79M 股份, $9.13B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据